Ht-Logo-gigapixel-icon
  • Menu
Search
Close this search box.
  • News
  • Opinion
  • Archives
  • Politics
  • Foreign Policy
  • Lobbying
  • Legislation
  • Policy
  • Hill Life & People
  • Podcast
  • News
  • Opinion
  • Archives
  • Politics
  • Foreign Policy
  • Lobbying
  • Legislation
  • Policy
  • Hill Life & People
  • Podcast
  • Free Trial
  • Get free News Updates
  • SIGN IN
  • SUBSCRIBE
  • Free Trial
  • Get free News Updates
  • SIGN IN
  • SUBSCRIBE
  • Get free News Updates
  • {email}
    • Administration
    • Account Settings
    • Logout
  • SUBSCRIBE
  • Get free News Updates
  • {email}
    • Administration
    • Account Settings
    • Logout
  • SUBSCRIBE
Ht-Logo-gigapixel-icon
  • Menu
Search
Close this search box.
  • Home Page
  • News
  • Opinion
  • Foreign Policy
  • Politics
  • Policy
  • Legislation
  • Lobbying
  • Hill Life & People
  • Hill Climbers
  • Heard On The Hill
  • Calendar
  • Archives
Menu
  • Home Page
  • News
  • Opinion
  • Foreign Policy
  • Politics
  • Policy
  • Legislation
  • Lobbying
  • Hill Life & People
  • Hill Climbers
  • Heard On The Hill
  • Calendar
  • Archives
My Account
  • Free Trial
  • Sign in
  • Free Trial
  • Sign in
  • Free Trial
  • Sign in
  • Free Trial
  • Sign in
Monday, November 4, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Monday, November 4, 2024 | Latest Paper
Subscribe Now

TRENDING:

  • PMO vetting
  • U.S. election
    • Michael Harris
    • Rose LeMay
  • de Adder’s Take
  • Heard on the Hill
  • Ukraine
  • PMO vetting
  • U.S. election
    • Michael Harris
    • Rose LeMay
  • de Adder’s Take
  • Heard on the Hill
  • Ukraine

Universal pharmacare benefits business and working families

The federal government can be on the right side of history as the upcoming election looms. Or, it can offer costly half measures that mostly benefit big pharma and the insurance industries and leave the rest of us out in the cold. The choice is clear.

This is the unfinished business of medicare, as contemplated by Tommy Douglas, right, pictured with Thérèse Casgrain in 1995, the visionary of our cherished health-care system, write Anita Huberman and Hassan Yussuff. Photograph courtesy of Wikimedia Commons
Opinion
BY ANITA HUBERMAN & HASSAN YUSSUFF
February 25, 2019
Opinion | BY ANITA HUBERMAN & HASSAN YUSSUFF | February 25, 2019

Sponsored content

Time for a shift: Canada must treat Alzheimer’s like other progressive diseases

sponsored content
4

Time for a shift: Canada must treat Alzheimer’s like other progressive diseases

Get The Policy Briefings Newsletter

Get into the weeds on hot policy issues and the players shaping them.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

More Opinion

Between wars and fears of fascism in the U.S., there’s plenty to be scared about

OpinionBY ROSE LEMAY

Poilievre can’t just ‘cat-call from the periphery’: Tom McElroy

Opinion

The problem of political homelessness

OpinionBY GERRY NICHOLLS

Liberals have fumbled green energy transition, and Conservatives have zero interest

OpinionBY DAVID CRANE

Trump alienates women and Puerto Rican voters

OpinionBY SHEILA COPPS

Related Stories

Feds must expand pharmacare to include essential drugs for our deadliest diseases: cancer, heart conditions, and stroke

OpinionBY ANDREA SEALE, DOUG ROTH

A prescription for equity: ensuring young Canadians’ health through National Pharmacare

OpinionBY STEVE MORGAN, MAEL HOUCK, HALEEMA AHMED

Multi-payer pharmacare will fail Canadians

OpinionBY STEVE MORGAN
Mark Holland

National pharmacare likely won’t help Canadians who need it the most

OpinionBY BACCHUS BARUA, JAKE FUSS

Private-public collaboration is key to unlocking healthcare for all

OpinionBY ZAHID SALMAN

News

  • Politics
  • Foreign Policy
  • Lobbying
  • Legislation
  • Policy Briefings
  • Politics This Morning
  • Hill Climbers
  • Civil Circles
  • Heard On The Hill
  • Election
  • Finance and Budget
  • Public Service
  • Exclusive Lists
  • Parliamentary Calendar
  • Top 100 Lists and Exclusive Features
  • Podcasts
  • This Week's Paper
  • Search
  • Archives
  • Digital Newspaper Archives

Get free news updates

Opinion

  • Andrew Caddell
  • Sheila Copps
  • David Crane
  • Jim Creskey
  • Gwynne Dyer
  • Michael Harris
  • Erica Ifill
  • Scott Taylor
  • Joe Jordan
  • Rose LeMay
  • Alex Marland
  • Gerry Nicholls
  • Gar Pardy
  • Tim Powers
  • Susan Riley
  • Douglas Roche
  • Ken Rubin
  • Bhagwant Sandhu
  • Les Whittington

Submit a guest opinion article

resources

  • The Wire Report
  • Hill Times Research Health
  • The Lobby Monitor
  • Parliament Now
  • Inside Ottawa Directory
  • Hill Times Careers
  • The Hill Times Store
  • Digital Newspaper Archives

Advertise

  • Media Kit

subscribe

  • Group subscriptions
  • Reuse and permissions

get help

  • About us
  • Contact us
  • Privacy Policy
  • Reset Password
  • Account settings
  • © The Hill Times 2024
Subscribe
  • Home Page
  • News
  • Opinion
  • Foreign Policy
  • Politics
  • Policy
  • Legislation
  • Lobbying
  • Hill Life & People
  • Hill Climbers
  • Heard On The Hill
  • Calendar
  • Archives
  • Home Page
  • News
  • Opinion
  • Foreign Policy
  • Politics
  • Policy
  • Legislation
  • Lobbying
  • Hill Life & People
  • Hill Climbers
  • Heard On The Hill
  • Calendar
  • Archives
  • Inside Ottawa Directory
  • Hill Times Store
  • Hill Times Careers
  • The Wire Report
  • The Lobby Monitor
  • Parliament Now
  • Inside Ottawa Directory
  • Hill Times Store
  • Hill Times Careers
  • The Wire Report
  • The Lobby Monitor
  • Parliament Now
  • Reuse & Permissions
  • Advertising
  • Reuse & Permissions
  • Advertising
  • Contact Us
  • Log In
  • Logout
  • Contact Us
  • Log In
  • Logout
CloseMenu
  • {email}
  • Account Settings
  • Logout
  • {email}
  • Account Settings
  • Logout